Amgen Inc. -- one of America's largest biotech and pharmaceutical companies -- has had a rough couple of months. In December, the firm was fined $762 million for illegally promoting drugs and defrauding Medicare. And now lawmakers from both sides of the aisle are looking to undo a little-noticed provision that Amgen successfully lobbied for [...]
[view whole blog post ]